The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

As anti-obesity drugs gain traction and thinness is increasingly equated with health, the movement to accept diverse body ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...